Analysis and comparison of OS, DSS and PFI revealed that SMURF1 and SMURF2 were expressed at higher levels in deceased pancreatic cancer patients compared to living patients (Figures 1A–C). This evidence concerns the gene SMURF2 and familial pancreatic carcinoma.